Leslie Grayson is a Neurology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 50 publications with 667 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
619 19th St S
Birmingham, AL 352491900
Telephone
205-975-0447Provider last certified this registry record 21 Sept 2021.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20257 payments
- UCB, Inc.Program year20251 payment
- JAZZ PHARMACEUTICALS INC.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
96.3%Other antiepileptics36.8%Levetiracetam42%Lacosamide28%Topiramate16%Epidiolex6%Levetiracetam Er5%Topiramate Er2%Keppra Xr1%Xcopri1%Part D<11 patientsMood Stabilizer13.3%Lamotrigine65%Lamictal Xr13%Carbamazepine8%Carbamazepine Er8%Valproic Acid7%Part D<11 patients+ 16 more classes in this area
Musculoskeletal
1.8%gamma-Aminobutyric Acid-ergic Agonist0.7%Baclofen100%Part D<11 patientsCentral alpha-2 Adrenergic Agonist0.7%Tizanidine Hcl100%Part D<11 patients+ 1 more class in this area
Cardiovascular
1.3%Beta blocker0.8%Propranolol Hcl100%Part D<11 patientsStatin0.5%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Neuroplastic changes in patients with functional seizures following neurobehavioral therapy
NeuroImage Clinical
2025 - Reduced Subjective Cognitive Concerns With Neurobehavioral Therapy in Functional Seizures and Traumatic Brain Injury
Journal of Neuropsychiatry
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”